eligibility for clinicaltrials:NCT00001475 [clinicaltrials_resource:7e9cc1e436e7b281b36c856a17800936]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT00001475 [clinicaltrials_resource:7e9cc1e436e7b281b36c856a17800936]
Bio2RDF identifier
7e9cc1e436e7b281b36c856a17800936
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7e9cc1e436e7b281b36c856a17800936
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
text [clinicaltrials_vocabulary:text]
IL-2 NAIVE PATIENTS:
...... or intolerance to thalidomide.
identifier
clinicaltrials_resource:7e9cc1e436e7b281b36c856a17800936
title
eligibility for clinicaltrials:NCT00001475
@en
type
label
eligibility for clinicaltrials ...... cc1e436e7b281b36c856a17800936]
@en